Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000977188 | SCV001125102 | likely benign | not provided | 2024-12-23 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000977188 | SCV004125593 | likely benign | not provided | 2022-09-01 | criteria provided, single submitter | clinical testing | USH2A: BP4, BP7 |
Genome- |
RCV003454975 | SCV004183037 | likely benign | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001272931 | SCV004183038 | likely benign | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001272931 | SCV001455382 | likely benign | Usher syndrome type 2A | 2020-05-01 | no assertion criteria provided | clinical testing | |
Clinical Genetics, |
RCV001700682 | SCV001926091 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000977188 | SCV001973674 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Institute of Human Genetics, |
RCV004818089 | SCV005070426 | likely benign | Retinal dystrophy | 2013-01-01 | no assertion criteria provided | clinical testing |